May 28, 2025
Purdue University and Dallara came together to celebrate the start of a partnership that will connect Purdue motorsports engineering students to the prominent industry leader in the heart of the world’s racing capital.
Purdue Motorsports and Dallara celebrate transformational partnership
May 28, 2025
Purdue University and Dallara came together to celebrate the start of a partnership that will connect Purdue motorsports engineering students to the prominent industry leader in the heart of the world’s racing capital.
Purdue Motorsports and Dallara celebrate transformational partnership
May 27, 2025
On May 20, 2025, the Food and Drug Administration announced a new stance on who should receive the COVID-19 vaccine.
May 27, 2025
On May 20, 2025, the Food and Drug Administration announced a new stance on who should receive the COVID-19 vaccine.
May 27, 2025
Purdue University’s Women’s Global Health Institute (WGHI) has announced six pilot research grant awards aimed at solving critical problems in women’s health and quality of life. Each project also advances Purdue’s efforts in interdisciplinary, translational research.
May 26, 2025
Inbreeding depression refers to the decline in performance caused by increased levels of inbreeding, which results from mating individuals with common ancestors.
Exploring Inbreeding Depression in Brazilian Angus Cattle Population Using Pedigree and Genomic Data
May 26, 2025
A new policy announced by the Trump administration may limit which Americans can get a COVID booster when respiratory virus season rolls around this fall and winter.
May 22, 2025
On May 20, 2025, the Food and Drug Administration announced a new stance on who should receive the COVID-19 vaccine.
May 22, 2025
The agency said it would approve new versions of the vaccine only for adults 65 years of age and older as well as for people with one or more risk factors for severe COVID-19 outcomes. These risk factors include medical conditions such as asthma, cancer, chronic kidney disease, heart disease and diabetes.
May 22, 2025
The agency said it would approve new versions of the vaccine only for adults 65 years of age and older as well as for people with one or more risk factors for severe COVID-19 outcomes.
